ADORA2A and acral lentiginous melanoma: Immune cells associated with acral melanoma exhibit the expression of multiple checkpoints including PD-1, LAG-3, CTLA-4, V-domain immunoglobin suppressor of T-cell activation (VISTA), TIGIT, and the adenosine A2A receptor (ADORA2).